February saw a major retreat in capital commitments, down nearly 50% from January. Nonetheless, Wefunder’s performance and the Healthcare & Pharmaceutical industry stand out in this month’s financial flow. Here are some key takeaways from private investing last month:
- February closed with $43.3 million in committed capital across equity and debt deals, down significantly from $84.5 million in September.
- Wefunder came out on top for Reg CF equity dollars invested for February 2024 with $6.3 million.
- Healthcare & Pharmaceutical was once again the most popular industry for the month, bringing in $3.3 million from Reg CF equity offerings.
- 39 equity deals closed in February: 36 Regulation CF deals and 3 Regulation A+ deals.
- In February, 117 new deals went live: 63 Reg CF equity deals, 4 Reg A+ equity deals, and 50 Reg CF debt deals.
